01 1Srini Pharmaceuticals
01 1LEVETIRACETAM USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-01-19
Pay. Date : 2023-01-17
DMF Number : 24757
Submission : 2011-03-15
Status : Active
Type : II
20
Srini Pharmaceuticals Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is LEVETIRACETAM USP, with a corresponding US DMF Number 24757.
Remarkably, this DMF maintains an Active status since its submission on March 15, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 19, 2023, and payment made on January 17, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
